Ajinomoto Bilan de santé

Santé financière contrôle des critères 5/6

Ajinomoto possède un total de capitaux propres de ¥833.3B et une dette totale de ¥491.4B, ce qui porte son ratio d'endettement à 59%. Son actif total et son passif total sont ¥1,733.9B et de ¥900.7B. L'EBIT de Ajinomoto est ¥153.5B ce qui fait que son ratio de couverture des intérêts 32. Elle dispose de liquidités et de placements à court terme de ¥176.5B.

Informations clés

59.0%

Ratio d'endettement

JP¥491.37b

Dette

Ratio de couverture des intérêts	32x
Argent liquide	JP¥176.54b
Fonds propres	JP¥833.27b
Total du passif	JP¥900.68b
Total des actifs	JP¥1.73t

Mises à jour récentes de la santé financière

Is Ajinomoto (TSE:2802) Using Too Much Debt?

Sep 23

Ajinomoto (TSE:2802) Has A Pretty Healthy Balance Sheet

Jun 12

Recent updates

Results: Ajinomoto Co., Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 09

Ajinomoto (TSE:2802) Shareholders Will Want The ROCE Trajectory To Continue

Oct 24

Is Ajinomoto (TSE:2802) Using Too Much Debt?

Sep 23

Ajinomoto Co., Inc. (TSE:2802) Shares Could Be 42% Below Their Intrinsic Value Estimate

Sep 08

Ajinomoto Co., Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Aug 07

Ajinomoto Co., Inc. Just Missed EPS By 9.3%: Here's What Analysts Think Will Happen Next

May 13

Is Ajinomoto Co., Inc. (TSE:2802) Trading At A 20% Discount?

Apr 22

With EPS Growth And More, Ajinomoto (TSE:2802) Makes An Interesting Case

Mar 14

Ajinomoto (TSE:2802) Is Looking To Continue Growing Its Returns On Capital

Feb 29

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 2802 ( ¥705.4B ) dépassent ses passifs à court terme ( ¥333.9B ).

Passif à long terme: Les actifs à court terme de 2802 ( ¥705.4B ) dépassent ses passifs à long terme ( ¥566.8B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 2802 ( 37.8% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de 2802 est passé de 48.5% à 59% au cours des 5 dernières années.

Couverture de la dette: La dette de 2802 est bien couverte par le flux de trésorerie opérationnel ( 40% ).

Couverture des intérêts: Les paiements d'intérêts de 2802 sur sa dette sont bien couverts par l'EBIT ( 32 x couverture).

Ajinomoto Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Is Ajinomoto (TSE:2802) Using Too Much Debt?

Ajinomoto (TSE:2802) Has A Pretty Healthy Balance Sheet

Recent updates

Results: Ajinomoto Co., Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Second quarter 2025 earnings: EPS exceeds analyst expectations

Ajinomoto Co., Inc. (TSE:2802) announces an Equity Buyback for 10,000,000 shares, representing 1.98% for ¥40,000 million.

Ajinomoto (TSE:2802) Shareholders Will Want The ROCE Trajectory To Continue

Is Ajinomoto (TSE:2802) Using Too Much Debt?

Upcoming dividend of JP¥40.00 per share

Ajinomoto Co., Inc. (TSE:2802) Shares Could Be 42% Below Their Intrinsic Value Estimate

Ajinomoto Co., Inc. to Report Q2, 2025 Results on Nov 07, 2024

Ajinomoto Co., Inc. Just Missed Earnings - But Analysts Have Updated Their Models

First quarter 2025 earnings: EPS misses analyst expectations

With Ajinomoto Co., Inc. (TSE:2802) It Looks Like You'll Get What You Pay For

Final dividend of JP¥40.00 announced

Now 21% undervalued

Returns Are Gaining Momentum At Ajinomoto (TSE:2802)

Ajinomoto (TSE:2802) Has A Pretty Healthy Balance Sheet

Now 21% undervalued

Ajinomoto Co., Inc. to Report Q1, 2025 Results on Aug 05, 2024

Ajinomoto Co., Inc. Just Missed EPS By 9.3%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Ajinomoto Co., Inc., Annual General Meeting, Jun 25, 2024

Ajinomoto Co., Inc. (TSE:2802) announces an Equity Buyback for 12,500,000 shares, representing 2.44% for ¥50,000 million.

Is Ajinomoto Co., Inc. (TSE:2802) Trading At A 20% Discount?

Now 20% undervalued after recent price drop

Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium

Upcoming dividend of JP¥37.00 per share

With EPS Growth And More, Ajinomoto (TSE:2802) Makes An Interesting Case

Ajinomoto Co., Inc. to Report Fiscal Year 2024 Results on May 09, 2024

Ajinomoto (TSE:2802) Is Looking To Continue Growing Its Returns On Capital

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Ajinomoto Co., Inc. to Report Q3, 2024 Results on Feb 06, 2024

Second quarter 2024 earnings: EPS misses analyst expectations

Upcoming dividend of JP¥37.00 per share at 1.3% yield

Ajinomoto Co., Inc. to Report Q2, 2024 Results on Nov 07, 2023

First quarter 2024 earnings released: EPS: JP¥51.77 (vs JP¥51.71 in 1Q 2023)

Price target increased by 8.4% to JP¥5,385

Ajinomoto Co., Inc. (TSE:2802) agreed to acquire remaining 25% stake in Ajinomoto Genexine Co., Ltd from Genexine, Inc. (KOSDAQ:A095700) for KRW 19.3 billion.

Ajinomoto Co., Inc. to Report Q1, 2024 Results on Aug 04, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Ajinomoto Co., Inc., Annual General Meeting, Jun 27, 2023

Ajinomoto Co., Inc. (TSE:2802) announces an Equity Buyback for 12,500,000 shares, representing 2.36% for ¥50,000 million.

Upcoming dividend of JP¥31.00 per share at 1.4% yield

Third quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

Ajinomoto Co., Inc. to Report Q3, 2023 Results on Jan 31, 2023

High number of new directors

Second quarter 2023 earnings: Revenues exceed analyst expectations

Ajinomoto Co., Inc. (TSE:2802) announces an Equity Buyback for 10,000,000 shares, representing 1.86% for ¥30,000 million.

Now 21% undervalued

Upcoming dividend of JP¥29.00 per share

Ajinomoto Co., Inc. to Report Q2, 2023 Results on Nov 07, 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: EPS exceeds analyst expectations

Ajinomoto Co., Inc., Annual General Meeting, Jun 23, 2022

High number of new directors

Upcoming dividend of JP¥24.00 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Second quarter 2022 earnings released: EPS JP¥58.73 (vs JP¥26.10 in 2Q 2021)

Upcoming dividend of JP¥22.00 per share

First quarter 2022 earnings released: EPS JP¥40.23 (vs JP¥40.78 in 1Q 2021)

Ajinomoto Co., Inc. (TSE:2802) announces an Equity Buyback for 25,000,000 shares, representing 4.55% for ¥40,000 million.

METabolic EXplorer S.A. (ENXTPA:METEX) completed the acquisition of Ajinomoto Animal Nutrition Europe S.A.S. from Ajinomoto Co., Inc. (TSE:2802).

Upcoming dividend of JP¥16.00 per share

Ajinomoto Co., Inc. Announces Changes in its Organization and Personnel, Effective April 1, 2021

New 90-day low: JP¥2,119

Third quarter 2021 earnings released: EPS JP¥47.40 (vs JP¥29.33 in 3Q 2020)

Earnings beat expectations, revenue disappoints

Analysts update estimates

New 90-day high: JP¥2,400

New 90-day high: JP¥2,346

Ajinomoto Co., Inc. Announces Personnel Change

Ajinomoto Co., Inc. Revised Earnings Guidance for the Full Year of Fiscal 2021

Ajinomoto Co., Inc. to Report Fiscal Year 2021 Results on May 10, 2021

Ajinomoto Co., Inc. to Report Q3, 2021 Results on Jan 29, 2021